熊去氧胆酸市场：按剂型、萃取方法、应用、通路和地区划分

2025 年全球熊去氧胆酸市场规模估计为 6.515 亿美元，预计到 2032 年将达到 13.031 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 10.4%。

数字。 2025 年熊去氧胆酸各地区市场占有率（%）

熊去氧胆酸是肝臟产生的胆汁酸，有助于摄取的脂肪的消化和吸收。它用于治疗各种肝臟相关疾病，如原发性胆汁性肝硬化 (PBC) 和胆结石。全球熊去氧胆酸市场的成长是由肝病盛行率的上升和对熊去氧胆酸在治疗中的好处的认识的提高所推动的。市场参与企业正在大力投资研发，以开发新的配方和上市形式的熊去氧胆酸，以扩大消费群。

市场动态

全球熊去氧胆酸市场的成长得益于易患肝损伤的老年人口不断增加、新兴市场医疗保健支出不断增加以及熊去氧胆酸作为 PBC 一线药物的应用日益广泛。然而，高昂的治疗费用和替代治疗方案的可用性可能会阻碍市场的成长。针对特定适应症的熊去氧胆酸製剂的开发和提高生物有效性的新技术的出现为市场相关人员提供了高成长机会。严格的药品审批规定可能会阻碍市场的成长。

研究的主要特点

本报告对全球熊去氧胆酸市场进行了详细分析，并以 2024 年为基准年，展示了预测期（2025-2032 年）的市场规模和復合年增长率 (CAGR%)。

它揭示了不同领域的潜在商机并解释了该市场的有吸引力的投资提案矩阵。

它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。

全球熊去氧胆酸市场的主要企业根据公司亮点、产品系列、关键亮点、财务绩效和策略等参数进行分析。

本研究涉及的主要企业包括 Dr. Falk Pharma、Daewoong Pharmaceutical、Teva Pharmaceutical、Mitsubishi Tanabe Pharma、Lannett Company 等。

本报告的见解将使负责人和公司经营团队能够就未来的产品发布、规模扩大、市场扩张和行销策略做出明智的决策。

全球熊去氧胆酸市场报告迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。

相关人员可以透过分析全球熊去氧胆酸市场所使用的各种策略矩阵来促进决策。

目录

第一章 调查目的与前提条件

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要
• 一致的机会图 (COM)

第三章市场动态、法规与趋势分析

• 市场动态
  • 驱动程式
  • 限制因素
  • 机会
• 影响分析
• 市场趋势
• 监管情景
• 收购和合作场景
• 资金筹措和投资
• PEST分析
• 波特的分析

4. 全球熊去氧胆酸市场 - 冠状病毒 (COVID-19) 大流行的影响

• 整体影响
• 政府倡议
• COVID-19 市场影响

5. 2020-2032 年全球熊去氧胆酸市场（以剂型划分）（百万美元）

• 介绍
• 固态的
• 液体

6. 2020-2032 年全球熊去氧胆酸市场（以萃取方法划分）（百万美元）

• 介绍
• 合成
• 生物

7. 2020 年至 2032 年全球熊去氧胆酸市场（按应用划分）（百万美元）

• 介绍
• 胃肠道疾病
• 肝臟疾病
• 囊肿纤维化
• 其他的

8. 2020-2032 年全球熊去氧胆酸市场按分销管道划分（百万美元）

• 介绍
• 医院药房
• 零售药局
• 网路药局

9. 2020-2032 年全球熊去氧胆酸市场（按地区划分）（百万美元）

• 介绍
• 北美洲
• 拉丁美洲
• 欧洲
• 亚太地区
• 中东
• 非洲

第十章 竞争格局

• 公司简介
  • Dipharma Francis Srl
  • ERREGIERRE SpA
  • Grindeks
  • Industria Chimica Emiliana
  • Mitsubishi Tanabe Pharma Corporation
  • Zhongshan Belling BIoTechnology Co.
  • Glenmark Pharmaceutical Limited
  • Abil Chempharma Private Limited
  • BIoTavia Labs Pvt Ltd
  • Daewoong Bio Inc.
  • PharmaZell GmbH
  • Suzhou Tianlu Bio-pharmaceutical Co., Ltd.
  • Dr. Falk Pharma
  • Teva Pharmaceuticals
  • Epic Pharma
  • Lannett Company, Inc.
  • Mylan NV
  • Bruschettini SpA
  • Impax Laboratories, Inc.
  • Shanghai Pharma

第 11 章 分析师建议

• 兴衰
• 一致的机会地图

第 12 章参考文献与调查方法

• 参考
• 调查方法

Global Ursodeoxycholic Acid Market is estimated to be valued at USD 651.5 Mn in 2025 and is expected to reach USD 1,303.1 Mn by 2032, growing at a compound annual growth rate (CAGR) of 10.4% from 2025 to 2032.

Figure. Ursodeoxycholic Acid Market Share (%), By Region 2025

Ursodeoxycholic acid is a bile acid produced by the liver that helps in digestion and absorption of consumed fats. It is prescribed for treating various liver related conditions such as primary biliary cirrhosis (PBC) and gallstones. Global ursodeoxycholic acid market growth is driven by rising prevalence of liver diseases and increasing awareness about benefits of ursodeoxycholic acid in their treatment. The market players are investing heavily in R&D to develop new formulations and delivery forms of ursodeoxycholic acid to expand consumer base.

Market Dynamics:

Global ursodeoxycholic acid market growth is driven by rising geriatric population prone to developing liver disorders, increasing healthcare expenditure in developing nations, and growing adoption of ursodeoxycholic acid as first line therapy for PBC. However, high treatment costs and availability of alternative treatment options can hamper the market growth. Development of ursodeoxycholic acid formulations targeted towards specific indications and emergence of novel technologies for enhancing its bioavailability present high growth opportunities for market players. Stringent regulations for drug approvals can hamper the market growth.

Key features of the study:

This report provides in-depth analysis of the global ursodeoxycholic acid market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global ursodeoxycholic acid market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Dr. Falk Pharma, Daewoong Pharmaceutical, Teva Pharmaceutical, Mitsubishi Tanabe Pharma, and Lannett Company

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global ursodeoxycholic acid market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global ursodeoxycholic acid market

Detailed Segmentation-

• Dosage Form Insights (Revenue, USD Mn, 2020 - 2032)
  • Solid Dosage Form
  • Liquid Dosage Form
• Mode of Extraction Insights (Revenue, USD Mn, 2020 - 2032)
  • Synthetic
  • Biological
• Application Insights (Revenue, USD Mn, 2020 - 2032)
  • Gastrointestinal Disorders
  • Liver Disorders
  • Cystic Fibrosis
  • Others
• Distribution Channel Insights (Revenue, USD Mn, 2020 - 2032)
  • Hospitals and Clinics
  • Retail Pharmacies
  • Online Pharmacies
• Regional Insights (Revenue, USD Mn 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Dipharma Francis Srl
  • ERREGIERRE S.p.A.
  • Grindeks
  • Industria Chimica Emiliana
  • Mitsubishi Tanabe Pharma Corporation
  • Zhongshan Belling Biotechnology Co.
  • Glenmark Pharmaceutical Limited
  • Abil Chempharma Private Limited
  • Biotavia Labs Pvt Ltd
  • Daewoong Bio Inc.
  • PharmaZell GmbH
  • Suzhou Tianlu Bio-pharmaceutical Co., Ltd.
  • Falk Pharma
  • Teva Pharmaceuticals
  • Epic Pharma
  • Lannett Company, Inc.
  • Mylan N.V.
  • Bruschettini S.p.A.
  • Impax Laboratories, Inc.
  • Shanghai Pharma

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Dosage Form
  • Market Snapshot, By Mode of Extraction
  • Market Snapshot, By Application
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Ursodeoxycholic Acid Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Ursodeoxycholic Acid Market, By Dosage Form, 2020 - 2032, (USD Mn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Solid Dosage Form
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Liquid Dosage Form
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Ursodeoxycholic Acid Market, By Mode of Extraction, 2020 - 2032, (USD Mn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Synthetic
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Biological
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Ursodeoxycholic Acid Market, By Application, 2020 - 2032, (USD Mn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Gastrointestinal Disorders
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Liver Disorders
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Cystic Fibrosis
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global Ursodeoxycholic Acid Market, By Distribution Channel, 2020 - 2032, (USD Mn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospital Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Retail Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Online Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

9. Global Ursodeoxycholic Acid Market, By Region, 2020 - 2032, (USD Mn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Mode of Extraction, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Mode of Extraction, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Mode of Extraction, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Mode of Extraction, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Mode of Extraction, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Mode of Extraction, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Mn)
    • North Africa
    • Central Africa
    • South Africa

10. Competitive Landscape

• Company Profiles
  • Dipharma Francis Srl
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • ERREGIERRE S.p.A.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Grindeks
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Industria Chimica Emiliana
  • Mitsubishi Tanabe Pharma Corporation
  • Zhongshan Belling Biotechnology Co.
  • Glenmark Pharmaceutical Limited
  • Abil Chempharma Private Limited
  • Biotavia Labs Pvt Ltd
  • Daewoong Bio Inc.
  • PharmaZell GmbH
  • Suzhou Tianlu Bio-pharmaceutical Co., Ltd.
  • Dr. Falk Pharma
  • Teva Pharmaceuticals
  • Epic Pharma
  • Lannett Company, Inc.
  • Mylan N.V.
  • Bruschettini S.p.A.
  • Impax Laboratories, Inc.
  • Shanghai Pharma

11. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

12. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact